Anti-cyclic citrullinated peptide antibody predicts the development of rheumatoid arthritis in patients with undifferentiated arthritis

被引:5
作者
Li Chun [1 ,2 ,3 ,4 ]
Zhang Yan [1 ,5 ,6 ,4 ]
Song Hui [1 ,5 ,6 ,4 ]
Gao Jie [1 ,7 ,8 ,4 ]
Zhao DongBao [1 ,7 ,8 ,4 ]
Zhu Qi [9 ,10 ,11 ,4 ]
He DongYi [9 ,10 ,11 ,4 ]
Wang Li [1 ,12 ,13 ,14 ,4 ]
Li XiangPei [1 ,12 ,13 ,14 ,4 ]
Liu XuDong [1 ,15 ,16 ,17 ,4 ]
Xiao WeiGuo [1 ,15 ,16 ,17 ,4 ]
Wu XinYu [9 ,18 ,19 ,20 ,4 ]
Wu HuaXiang [9 ,18 ,19 ,20 ,4 ]
Tu Wei [1 ,21 ,22 ,23 ,4 ]
Hu ShaoXian [1 ,21 ,22 ,23 ,4 ]
Wang Xin [9 ,24 ,25 ,26 ,4 ]
Li ZhiJun [9 ,24 ,25 ,26 ,4 ]
Lu ZhiMin [1 ,27 ,28 ,29 ,4 ]
Da ZhanYun [1 ,27 ,28 ,29 ,4 ]
Liang Bo [1 ,30 ,31 ,4 ]
Liu XiaoMin [1 ,30 ,31 ,4 ]
Zhao JinWei [32 ,33 ,34 ,4 ]
Li Ling [32 ,33 ,34 ,4 ]
Han Feng [1 ,35 ,36 ,4 ]
Qi WuFang [1 ,35 ,36 ,4 ]
Wei Wei [1 ,37 ,38 ,4 ]
Ma Xu [1 ,39 ,40 ,41 ,4 ]
Li ZhenBin [1 ,39 ,40 ,41 ,4 ]
Zheng GuiMin [1 ,42 ,40 ,43 ,4 ]
Zhang FengXiao [1 ,42 ,40 ,43 ,4 ]
Li Yi [9 ,44 ,45 ,46 ,4 ]
Wang YouLian [9 ,44 ,45 ,46 ,4 ]
Ling GuangHui [47 ,48 ,49 ,50 ,4 ]
Chen JinWei [47 ,48 ,49 ,50 ,4 ]
Hou XiaoQiang [1 ,51 ,52 ,53 ,4 ]
Zhang Jing [54 ,55 ,56 ,57 ,4 ]
Chen QingPing [54 ,55 ,56 ,57 ,4 ]
Liu ChangLian [58 ,55 ,56 ,57 ,4 ]
Zhang Yan [59 ,60 ,61 ,62 ,4 ]
Zeng JiaShun [59 ,60 ,61 ,62 ,4 ]
Zou QingHua [9 ,63 ,64 ,4 ]
Fang YongFei [9 ,63 ,64 ,4 ]
Su Yin
Li ZhanGuo [1 ,2 ,3 ,4 ]
机构
[1] Department of Rheumatology and Immunology
[2] Peking University People’s Hospital
[3] Beijing
[4] China
[5] Beijing Jishuitan Hospital
[6] Changhai Hospital
[7] Shanghai
[8] Department of Rheumatology
[9] Shanghai Guanghua Hospital of Integrated Traditional Chinese and Western Medicine
[10] Anhui Provincial Hospital
[11] Hefei
[12] Anhui
[13] The First Hospital of China Medical University
[14] Shenyang
[15] Liaoning
[16] The Second Affiliated Hospital of Zhejiang University School of Medicine
[17] Hangzhou
[18] Zhejiang
[19] Tongji Hospital
[20] Wuhan
[21] Hubei
[22] The First Affiliated Hospital of Bengbu Medical College
[23] Bengbu
[24] Affiliated Hospital of Nantong University
[25] Nantong
[26] Jiangsu
[27] The Hospital of Shunyi District Beijing
[28] Department of Infection and Immunology
[29] Tianjin Union Medical Center
[30] Tianjin
[31] Tianjin First Central Hospital
[32] Tianjin Medical University General Hospital
[33] Peace Hospital
[34] Shijiazhuang
[35] Hebei
[36] Hebei General Hospital
[37] Jiangxi Provincial People’s Hospital
[38] Nanchang
[39] Jiangxi
[40] Division of Rheumatology and Immunology
[41] The Second Xiangya Hospital of Central South University
[42] Changsha
[43] Hunan
[44] The First College of Clinical Medical Science of China Three Gorges University & Yichang Central People’s Hospital
[45] Yichang
[46] Department of Rheumatology and Immunology I Wald
[47] Xi’an No Hospital
[48] Xi’an
[49] Shaanxi
[50] Department of Rheumatology and Immunology V Wald
关键词
Anti-cyclic citrullinated peptide antibody; Arthritis, Rheumatoid; Rheumatoid factor; Undifferentiated arthritis;
D O I
暂无
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Background: Clinical outcomes of undifferentiated arthritis (UA) are diverse, and only 40% of patients with UA develop rheumatoid arthritis (RA) after 3 years. Discovering predictive markers at disease onset for further intervention is critical. Therefore, our objective was to analyze the clinical outcomes of UA and ascertain the predictors for RA development.Methods: We performed a prospective, multi-center study from January 2013 to October 2016 among Chinese patients diagnosed with UA in 22 tertiary-care hospitals. Clinical and serological parameters were obtained at recruitment. Follow-up was undertaken in all patients every 12 weeks for 2 years. Predictive factors of disease progression were identified using multivariate Cox proportional hazards regression.Results: A total of 234 patients were recruited in this study, and 17 (7.3%) patients failed to follow up during the study. Among the 217 patients who completed the study, 83 (38.2%) patients went into remission. UA patients who developed RA had a higher rheumatoid factor (RF)-positivity (42.9%vs. 16.8%, χ2 = 8.228,P = 0.008), anti-cyclic citrullinated peptide (CCP) antibodypositivity (66.7%vs. 10.7%, χ2 = 43.897,P < 0.001), and double-positivity rate of RF and anti-CCP antibody (38.1%vs. 4.1%, χ2 = 32.131,P < 0.001) than those who did not. Anti-CCP antibody but not RF was an independent predictor for RA development(hazard ratio 18.017, 95% confidence interval: 5.803–55.938;P < 0.001).Conclusion: As an independent predictor of RA, anti-CCP antibody should be tested at disease onset in all patients with UA.
引用
收藏
页码:2899 / 2904
页数:6
相关论文
共 37 条
[1]   Efficacy and Safety of Tofacitinib in Chinese Patients with Rheumatoid Arthritis [J].
Li, Zhan-Guo ;
Liu, Yi ;
Xu, Hu-Ji ;
Chen, Zhi-Wei ;
Bao, Chun-De ;
Gu, Jie-Ruo ;
Zhao, Dong-Bao ;
An, Yuan ;
Hwang, Lie-Ju ;
Wang, Lisy ;
Kremer, Joel ;
Wu, Qi-Zhe .
CHINESE MEDICAL JOURNAL, 2018, 131 (22) :2683-+
[2]   Abatacept reduces disease activity and ultrasound power Doppler in ACPA-negative undifferentiated arthritis: a proof-of-concept clinical and imaging study [J].
Buch, Maya H. ;
Hensor, Elizabeth M. A. ;
Rakieh, Chadi ;
Freeston, Jane E. ;
Middleton, Edward ;
Horton, Sarah ;
Das, Sudipto ;
Peterfy, Charles ;
Tan, Ai Lyn ;
Wakefield, Richard J. ;
Emery, Paul .
RHEUMATOLOGY, 2017, 56 (01) :58-67
[3]   Validation of Leiden Score in Predicting Progression of Rheumatoid Arthritis in Undifferentiated Arthritis in Indian Population [J].
Ghosh, K. ;
Chatterjee, A. ;
Ghosh, S. ;
Chakraborty, S. ;
Chattopadhyay, P. ;
Bhattacharya, A. ;
Pal, M. .
ANNALS OF MEDICAL AND HEALTH SCIENCES RESEARCH, 2016, 6 (04) :205-210
[4]   Early therapeutic intervention with methotrexate prevents the development of rheumatoid arthritis in patients with recent-onset undifferentiated arthritis: A prospective cohort study [J].
Kudo-Tanaka, Eriko ;
Shimizu, Takashi ;
Nii, Takuro ;
Teshigawara, Satoru ;
Yoshimura, Maiko ;
Watanabe, Akane ;
Tsuji, Soichiro ;
Tsuboi, Hideki ;
Hirao, Makoto ;
Yura, Akiko ;
Harada, Yoshinori ;
Sueishi, Makoto ;
Suenaga, Yasuo ;
Chiba, Noriyuki ;
Tonai, Takeharu ;
Saisho, Koichiro ;
Ogata, Atsushi ;
Matsushita, Masato ;
Hashimoto, Jun ;
Ohshima, Shiro ;
Tohma, Shigeto ;
Saeki, Yukihiko .
MODERN RHEUMATOLOGY, 2015, 25 (06) :831-836
[5]   Application of a prediction model for the progression of rheumatoid arthritis in patients with undifferentiated arthritis [J].
Arana-Guajardo, Ana ;
Perez-Barbosa, Lorena ;
Vega-Morales, David ;
Riega-Torres, Janett ;
Esquivel-Valerio, Jorge ;
Garza-Elizondo, Mario .
REUMATOLOGIA CLINICA, 2014, 10 (06) :360-363
[6]   Diagnosis and classification of reactive arthritis [J].
Selmi, Carlo ;
Gershwin, M. Eric .
AUTOIMMUNITY REVIEWS, 2014, 13 (4-5) :546-549
[7]   Clinical features and independent predictors in the further development of rheumatoid arthritis in undifferentiated arthritis [J].
Chen, Dongying ;
Li, Hao ;
Liang, Liuqin ;
Xiao, Youjun ;
Xu, Ting ;
Qiu, Qian ;
Lian, Fan ;
Zhan, Zhongping ;
Ye, Yujin ;
Xu, Hanshi ;
Yang, Xiuyan .
RHEUMATOLOGY INTERNATIONAL, 2013, 33 (11) :2827-2832
[8]   Drug therapy in undifferentiated arthritis: a systematic literature review [J].
Wevers-de Boer, K. V. C. ;
Heimans, L. ;
Huizinga, T. W. J. ;
Allaart, C. F. .
ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 (09) :1436-1444
[9]  
Brief Report: Anti–Carbamylated Protein Antibodies Are Present in Arthralgia Patients and Predict the Development of Rheumatoid Arthritis.[J].Jing Shi;Lotte A. van de Stadt;E. W. Nivine Levarht;Tom W. J. Huizinga;René E. M. Toes;Leendert A. Trouw;Dirkjan van Schaardenburg.Arthritis & Rheumatism.2013, 4
[10]   Induction therapy with a combination of DMARDs is better than methotrexate monotherapy: first results of the tREACH trial [J].
de Jong, P. H. ;
Hazes, J. M. ;
Barendregt, P. J. ;
Huisman, M. ;
van Zeben, D. ;
van der Lubbe, P. A. ;
Gerards, A. H. ;
de Jager, M. H. ;
de Sonnaville, P. B. ;
Grillet, B. A. ;
Luime, J. J. ;
Weel, A. E. .
ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 (01) :72-78